Syncona Limited Notice of Results
18 Octubre 2024 - 1:00AM
RNS Regulatory News
RNS Number : 6765I
Syncona Limited
18 October 2024
18 October 2024
Syncona
Limited
Notice of Interim
Results
Syncona Ltd, ("Syncona" or the
"Company") a leading life science investor focused on creating, building and scaling global leaders in life
science, will announce its interim results for the period ended 30
September 2024 on Thursday 14 November 2024.
An in-person presentation for
analysts will take place at 09.00am GMT, with a webcast available
on the Company's website at https://www.synconaltd.com/investors/results-and-presentations/
or via this
link.
[ENDS]
Enquiries
Syncona Ltd
Natalie Garland-Collins / Fergus
Witt
Tel: +44 (0) 20 3981 7912
FTI Consulting
Ben Atwell / Tim Stamper
Tel: +44 (0) 20 3727 1000
About Syncona
Syncona's purpose is to invest to
extend and enhance human life. We do this by creating, building and
scaling companies to deliver transformational treatments to
patients in areas of high unmet need.
We aim to build and maintain a
diversified portfolio of 20-25 globally leading life science
businesses, across development stage, modality and therapeutic
area, for the benefit of all our stakeholders. We focus on
developing treatments that deliver patient impact by working in
close partnership with world-class academic founders and
experienced management teams. Our balance sheet underpins our
strategy, enabling us to take a long-term view as we look to
improve the lives of patients with no or poor treatment options,
build sustainable life science companies and deliver strong
risk-adjusted returns to shareholders.
Syncona Limited seeks to achieve returns over the long term.
Investors should seek to ensure they understand the risks and
opportunities of an investment in Syncona Limited, including the
information in our published documentation, before
investing.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NORQKOBDOBDDFKD
Syncona (LSE:SYNC)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
Syncona (LSE:SYNC)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024